Published in

American Association for the Advancement of Science, Science Translational Medicine, 480(11), 2019

DOI: 10.1126/scitranslmed.aat2189

Links

Tools

Export citation

Search in Google Scholar

Challenges for mesenchymal stromal cell therapies

This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Green circle
Postprint: archiving allowed
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

Clinical trials of mesenchymal stromal cell therapies reveal a challenging heterogeneous landscape, including diverse therapeutic targets, patient categories, cell sources, and potential mechanisms of action.